Biosimilar Market To Set Massive CAGR of 25.1% by 2032 | Industry Growth Report by IMARC Group
BROOKLYN, NY, USA, May 29, 2024 /EINPresswire.com/ -- IMARC Group, a leading market research company, has recently released a report titled "Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, …